FindTrial
Sign In

Comparative evaluation levobupivacaine and bupivacaine for cesarean section under spinal anaesthesia.

Comparative evaluation of hyperbaric levobupivacaine and hyperbaric bupivacaine for category 3 and 4 cesarean section under spinal anaesthesia.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051661
Enrollment
100
Registered
2023-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Spinal Anesthesia: Spinal Anesthesia in category 3 and 4 ceserean section Control Intervention1: Hyperbaric Levobupivacaine and Bupivacaine: DOSE:12.5mg of hyperbaric levobupivacaine an

Sponsors

MLB Medical College, Jhansi
Lead Sponsor
Department of Obstretrics and Gynaecology
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Category 3 and 4 ceserean section

Exclusion criteria

Exclusion criteria: Patient refusal, contraindication to spinal anaesthesia, allergy to local anesthetics, fused spine , musculoskeletal abnormalities, coagulation defects.

Design outcomes

Primary

MeasureTime frame
Comparison of sensory and motor block characteristics in the two groupsTimepoint: 1) Sensory parameters Time to onset of sensory block (min) Time for the sensory block to reach T10 (min) Time for the sensory block to reach maximum level (min) Maximum sensory level (T dermatome) Time to regression by two dermatomes for the sensory block (min) Regression time to T12 for the sensory block (min) 2)Motor Parameters Time to onset of motor block (min) Time to maximum motor block level (min) Regression time for the motor block (min)—

Secondary

MeasureTime frame
Hemodynamic ParametersTimepoint: Every 10 mins in intraoperative period and 2hrly for 12 hrs postoperatively.—

Countries

India

Contacts

Public ContactDr Anshul Jain

Maharani Laxmibai Medical College

dranshulrachna@gmail.com9411685406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026